baber/WOPTO huggingface dataset:
Patent AU-2003265746-B2 (AU)
Title: Atmosphere control during continuous heat treatment of metal strips
Inventor: CRUTZEN JEAN-PIERRE
IPC: G11B33/04
Filed: 2003-09-11
Granted: 2008-10-30
Abstract: A method for heat treating metallic strips inside a heat treatment chamber at a pressure greater than atmospheric pressure including passing the strips through at least one heating zone of the chamber and moving the strip through at least one cooling zone of the chamber. A first protective gas atmosphere containing nitrogen and hydrogen and/or helium is established in all but at least one cooling zone. The at least one cooling zone has a second protective atmosphere containing nitrogen and a second amount of hydrogen, the second amount of hydrogen is greater than the first amount. Nitrogen is introduced into the chamber, and a protective gas containing a third hydrogen content greater than the second hydrogen content is injected into the cooling zone, producing a gas exchange between one zone of the chamber having the first protective atmosphere and the cooling zone, and controlling the flow of introduction and injection.
Patent AU-2003271583-B2 (AU)
Title: Transgenic expression cassettes for expressing nucleic acid sequences in sink tissues of plants that store carbohydrate
Inventor: SONNEWALD UWE
IPC: C12N15/82
Filed: 2003-09-05
Granted: 2008-11-20
Abstract: The invention relates to methods for the directed, transgenic expression of nucleic acid sequences in the carbohydrate-storing sink tissues of plants using transgenic expression cassettes which comprise the Vicia faba plastidic 1,4-alpha-D-glucan:phosphate alpha-D-glucosyltransferase promoter. Furthermore, the invention relates to said transgenic expression cassettes and to transgenic expression vectors and transgenic organisms comprising them, and to the use of the same for the production of foodstuffs, feedstuffs, seed, pharmaceuticals or fine chemicals.
Patent AU-2003280442-B2 (AU)
Title: Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
Inventor: ULLRICH STEFAN
IPC: A61K38/17
Filed: 2003-06-23
Granted: 2009-02-05
Abstract: A method for enhancing the therapeutic effect of cytokine treatment is disclosed. More specifically the present invention relates to a method for administering to a tumor patient a therapeutic dose of cytokine in combination with antibodies directed against the tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN). The improved treatment method is characterized in a significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone, resulting in a positive therapeutic response with respect to that observed with single anti-tumor agents alone.
Patent AU-2003287304-B2 (AU)
Title: Apparatus for phase angle monitoring of plurality of vibrating machines
Inventor: STEFFES EDWARD CHARLES JR
IPC: G01M7/02
Filed: 2003-10-31
Granted: 2008-09-04
Abstract: A phase angle monitoring apparatus for phase monitoring a vibratory system includes a controller that produces a phase angle control signal representative of the lead or lag between the vibratory movement of two vibrating masses. The phase angle control signal is coupled to at least one of the vibrating masses to adjust the vibration of the mass to produce a desired phase angle, for example one-hundred eighty degrees (180°).
Patent AU-2003297994-B2 (AU)
Title: Passive sensors for automatic faucets and bathroom flushers
Inventor: HERBERT KAY
IPC: F16K31/02
Filed: 2003-12-04
Granted: 2010-01-21
Abstract: An automatic toilet room flusher (100) includes a valve having a valve body (512) and, a valve member, and a controller (500). The valve body includes an inlet 112, an outlet 113, and a valve seat inside the body. The valve member (e.g., a flexible diaphragm, a piston or a fram piston) is cooperatively arranged with the valve seat. The valve member is constructed and arranged to control water flow between the inlet and the outlet. The flusher may include a passive optical sensor or an active optical sensor. The active optical sensor includes a light emitter and a light detector. The passive optical sensor includes only a light detector sensitive to ambient (room) light for providing a signal to a controller. The controller executes one or several novel algorithms.
Patent AU-2003302067-B2 (AU)
Title: Hydrogen peroxide disinfectant containing an acid and/or an alcohol
Inventor: RAMIREZ JOSE A
IPC: A01N59/14
Filed: 2003-11-14
Granted: 2009-03-12
Abstract: An aqueous disinfecting solution and dry powdered composition which may be dissolved in water to provide the solution. The solution has a pH of from 0.6 to 7 and comprises (a) hydrogen peroxide in a concentration of from 0.01 to 6% w/w; and (b) at least one component chosen from cyclic carboxylic acids and aromatic alcohols, in a concentration of from 0.01 to 4 w/w %, all based on the total weight of the solution. The cyclic carboxylic acids are preferably 2-furan carboxylic acid, benzoic acid and salicylic acid. Furthermore, the solution preferably contains at least one C6-C12 alkyl diphenyl sulfonate surfactant and a nonionic surfactant Additional optional ingredients include anionic surfactants, corrosion inhibitors, cation sequestering agents, and buffers,
Patent AU-2004266210-B2 (AU)
Title: Wire marker label media
Inventor: WILKEN KEVIN L
IPC: B41J15/04
Filed: 2004-08-09
Granted: 2009-12-03
Abstract: A label media for use in a label media printer forms dynamically sized label markers. The label media includes a continuous tube affixed to a length of a carrier web. Indicia is printed on the tube which is then cut to a desired length that accommodates the indicia printed thereon to dynamically form the wire marker.
Patent AU-2004269793-B2 (AU)
Title: Systems with interchangeable horns for producing encased products and related methods, computer program products and horn rotor assemblies
Inventor: POLING KIM L
IPC: A23P1/08
Filed: 2004-09-08
Granted: 2010-09-30
Abstract: Computer program products are configured to allow dual operational modes of packaging systems to produce encased products using interchangeable first or second horns.
Patent AU-2004292297-B2 (AU)
Title: Digital video surveillance
Inventor: GRINDSTAFF GENE A
IPC: G08B1/00
Filed: 2004-11-17
Granted: 2009-11-19
Abstract: A control system for use with one or more video surveillance cameras forming a video surveillance system. The control system includes a video database module wherein a database entry includes at least one sensor condition defining an alarm state for each camera. Additionally, there is an alarm condition module that receives one or more sensor signals from one or more sensors associated with a camera and retrieves the sensor condition defining an alarm state for the camera. The alarm condition module outputs an alarm signal if the alarm condition module determines that the one or more sensor signals meets the one or more sensor conditions. The control system is modular and may be distributed in a network environment. The control system also monitors the network bandwidth and can adjust the throughput of digital data representing the digital images in order to avoid any bandwidth limitations.
Patent AU-2005205240-B2 (AU)
Title: Human hepatic progenitor cells and methods of use thereof
Inventor: HOLGERSSON SUCHITRA
IPC: A61K35/12
Filed: 2005-01-14
Granted: 2011-04-21
Abstract: Liver progenitor cells immunoreactive for CD117, as well as for CD34 capable of proliferating in a culture; and differentiating in vivo into a hepatocyte, a cholangiocyte or a sinusoidal cell are provided. The cultures can be expanded over a large number of passages and integrate well after transplantation into adult liver.
Patent AU-2005215769-B2 (AU)
Title: System and method for motion-controlled foot unit
Inventor: THORHALLSDOTTIR HJORDIS
IPC: A61F2/50
Filed: 2005-02-11
Granted: 2012-01-19
Abstract: A system and method associated with the movement of a limb. In one example, the system, such as a prosthetic or orthotic system, includes an actuator (116) that actively controls, or adjusts, the angle between a foot unit (104) and a lower limb member (102). A processing module may control movement of the actuator (116) based on data obtained from a sensor module. For instance, sensing module data may include information relating to the gait of a user and may be used to adjust the foot unit to substantially mimic the movement of a natural, healthy ankle. The system may further accommodate, for example, level ground walking, traveling up/down stairs, traveling up/down sloped surfaces, and various other user movements. In addition, the processing module may receive user input or display output signals through an external interface. For example, the processing module may receive a heel height input from the user.
Patent AU-2005270305-B2 (AU)
Title: Piperazine derivatives with CCR3 inhibiting activity
Inventor: LEGRAND DARREN MARK
IPC: C07D409/12
Filed: 2005-08-09
Granted: 2009-09-10
Abstract: Compounds of formula I in free or salt form, wherein Ar, R1, R2, R3, X and T have the meanings as indicated in the specification, are useful for treating a condition mediated by CCR-3, particularly an inflammatory or allergic condition such as an inflammatory or obstructive airways disease. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
Patent AU-2005282751-B2 (AU)
Title: Method and composition for forming a non-chrome conversion coating on steel surface
Inventor: MELZER JEFF I
IPC: C23C22/83
Filed: 2005-08-30
Granted: 2011-07-21
Abstract: Chromate free treatments and compositions for applying a conversion or passivation coating to metal surfaces. Preferred compositions comprise a film forming latex polymer, fluoacid, phosphoric acid, and a polyoxyethylene/oxypropylene block copolymer. The requisite metal surfaces are contacted by the compositions and dried. Rinsing is optional.
Patent AU-2005316313-B2 (AU)
Title: Novel MCH receptor antagonists
Inventor: MICHAEL GREENEN PETER
IPC: C07D263/58
Filed: 2005-12-16
Granted: 2011-09-29
Abstract: The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein Ar, L, R, q, X, R, R, R, and R are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
Patent AU-2005316727-B2 (AU)
Title: Apparatus and method for producing hydrogen
Inventor: SPENCER WHEAT W
IPC: B01J19/00
Filed: 2005-12-09
Granted: 2011-07-21
Abstract: An apparatus and method for producing hydrogen. The apparatus includes a fuel processor, a purification unit and a system controller. The controller determines a calculated flow of reformate from the fuel processor and operates the purification unit based on the calculated flow. The calculated flow is derived from a process model of the fuel processor and known feed(s) to the fuel processor. The calculated flow of reformate is used to control the flow of reformate to adsorbent beds within the purification unit and can be used to control other materials flows within the apparatus. Means for reducing fluctuations in the pressure and/or flow rate of reformate flowing from the fuel processor to the purification unit are also disclosed. The purity of the hydrogen produced can be maintained by adjusting the operation of the purification unit in response to changes in reformate composition, pressure and/or flow rate.
Patent AU-2006235568-B2 (AU)
Title: Method and system for an assessment within a multi-level organization
Inventor: GREG RITTER
IPC: G06Q10/00
Filed: 2006-04-12
Granted: 2011-07-14
Abstract: A system of hardware and software provides a systematic and systemic method for performing assessment of the effectiveness of different levels within an institution. The system includes template driven definitions that span multiple tiers of hierarchically arranged operating units within the institution thereby providing flexibility and customization to handle a user-definable model of the institution's organization. The system includes import/export functionality, robust institutional modeling, program initiatives, curriculum mapping techniques, customizable assignment binders, and selective dissemination of documents.
Patent AU-2006277927-B2 (AU)
Title: Device for opening and closing of tarpaulins for covering the bodies of industrial, agricultural and similar vehicles
Inventor: PIVETTA CESARINO
IPC: B60J7/06
Filed: 2006-08-04
Granted: 2012-05-10
Abstract: Device for opening and closing control of tarpaulins for covering the bodies of industrial, agricultural and/or similar vehicles, in which the operating device 11 comprises drive pulleys 28 and diverter pulleys 26 which run along the cable 17. The operating device 11 is fixed on the first strut 21a and via its movement, controlled by the gear motor 13, closes or opens the tarpaulin on the body.
Patent AU-2006279299-B2 (AU)
Title: Wireless user network for handheld information terminals
Inventor: MCCARTEN DAVID J
IPC: H04W4/029
Filed: 2006-08-21
Granted: 2011-12-08
Abstract: An example user network (100) provides information and entertainment for users via handheld information terminals (106). The "look and feel" and personally of the handheld information terminals can be location-specific so that the most relevant information and entertaiment can be provided to users in auseful and appealing manner.
Patent AU-2006315071-B2 (AU)
Title: Device for monitoring motion of a movable closure
Inventor: DANG TOAN
IPC: E05F15/10
Filed: 2006-11-16
Granted: 2011-07-28
Abstract: A device for monitoring motion of a movable closure arranged for travel between limit positions, comprising an absolute position encoder for identifying whether the closure is in one of a plurality of sectors of travel, a relative position encoder for monitoring the speed and relative position of the closure, and a drive means for operatively coupling the relative position encoder and the absolute position encoder to the closure, such that there is a fixed relationship between motion of the closure and movement of both encoders, wherein the absolute position encoder features an adjustment assembly comprising a first element and a second element, the first element being selectively adjustable in position relative to the second element to adjust the absolute position encoder without movement of the drive means or the relative position encoder.
Patent AU-2006327892-B2 (AU)
Title: Histone deacetylase inhibitors for enhancing activity of antifungal agents
Inventor: WENQI HU
IPC: A61K31/506
Filed: 2006-12-19
Granted: 2011-12-22
Abstract: The present invention relates to compounds, compositions thereof and methods to selectively treat fungal infections More particularly this invention relates to compounds, compositions thereof and methods for selectively enhancing fungal sensitivity to antifungal compounds The compounds are hydroxamate-based inhibitors of histone deacetylase (HDAC) which show synergistic activity with antifungal agents against fungal species at concentrations of inhibitor non toxic to mammalian cells.
Patent AU-2007202938-B2 (AU)
Title: Methods of modulating CD200 receptors
Inventor: BIGLER MICHAEL E
IPC: A61P43/00
Filed: 2007-06-26
Granted: 2011-01-20
Abstract: Provided are methods for modulating activity of the immune system using agonists or antagonists of a CD200 receptor. Also provided are methods of treatment 5 and diagnosis of immune disorders.
Patent AU-2007269235-B2 (AU)
Title: Multiple-batch system and method for loading railcars of a wide range of capacities and designs
Inventor: WALKER HAROLD A
IPC: G01G13/00
Filed: 2007-06-29
Granted: 2014-01-23
Abstract: Multiple-batch train loading systems (20) and methods, for example for loading coal (42), which are capable of accommodating railcars (22, 24, 26) of a wide range of capacities and designs. Each railcar (22, 24, 26) is loaded with at least a relatively large initial weighed batch (100) having a weight at least approximately equal to the maximum available capacity of a weigh bin (46), and a relatively small final weighed batch (102). The initial weighed batch (100) and the final weighed batch (102) are both made up with precision. If required, one or more intermediate weighed batches (104) are loaded into the railcar (22, 24, 26). The intermediate batches (104), if required, are made up rapidly, but not necessarily with precision.
Patent AU-2007296964-B2 (AU)
Title: Nicotinic acid derivatives as modulators of metabotropic glutanate receptors
Inventor: UMBRICHT DANIEL
IPC: C07D403/06
Filed: 2007-09-10
Granted: 2012-05-31
Abstract: The invention concerns the use an mGluR modulator, e.g. an mGluR5 modulator, for the treatment, prevention or delay of progression of cognitive dysfunction.
Patent AU-2007301838-B2 (AU)
Title: New derivatives of 5-thioxilopyranose
Inventor: BONDOUX MICHEL
IPC: A61K31/70
Filed: 2007-09-26
Granted: 2012-11-01
Abstract: The invention relates to new compounds of 5-thioxilose, preferably derivatives of the 5-thioxilopyranose type, and to a method for preparing the same and their use as the active ingredient of drugs mainly intended for treating or preventing thrombosis or heart failure or thromboembolic diseases.
Patent AU-2007313715-B2 (AU)
Title: Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity
Inventor: GRIFFIN JOHN H
IPC: A61K38/17
Filed: 2007-10-30
Granted: 2013-01-10
Abstract: Variants (mutants) of recombinant activated protein C (APC) or recombinant protein C (prodrug, capable of being converted to APC) that have substantial reductions in anticoagulant activity but that retain normal levels of anti-apoptotic activity are provided. Three examples of such recombinant APC mutants are KKK191-193AAA-APC, RR229/230AA-APC, and RR229/230AA plus KKK191-193AAA-APC. APC variants and prodrugs of the invention have the desirable property of being cytoprotective (anti-apoptotic effects), while having significantly reduced risk of bleeding. The invention also provides a method of using the APC variants or prodrugs of the invention to treat subjects who will benefit from APC's cytoprotective activities that are independent of APC's anticoagulant activity. These subjects include patients at risk of damage to blood vessels or tissue in various organs caused, at least in part, by apoptosis. At risk patients include, for example, those suffering (severe) sepsis, ischemia/reperfusion injury, ischemic stroke, acute myocardial infarction, acute or chronic neurodegenerative diseases, or those undergoing organ transplantation or chemotherapy, among other conditions. Methods of screening for variants of recombinant protein C or APC that are useful in accordance with the invention are also provided.
Patent AU-2007323246-B2 (AU)
Title: Depsipeptides and their therapeutic use
Inventor: CECIL ALEXANDER RICHARD LIAM
IPC: C07K5/02
Filed: 2007-11-23
Granted: 2012-04-19
Abstract: Compounds which are Spiruchostatin analogues of the general formula (I) or (I'), isosteres thereof and pharmaceutically acceptable salts thereof are found to inhibit HDAC wherein R, R, R and R are the same or different and represent an amino acid side chain moiety and each R is the same or different and represents hydrogen or C-C alkyl.
Patent AU-2007338681-B2 (AU)
Title: Substituted tetracycline compounds for treatment of inflammatory skin disorders
Inventor: MOLNAR DENNIS P
IPC: A61P17/00
Filed: 2007-12-21
Granted: 2013-09-26
Abstract: Methods and compositions for the treatment of skin disorders (
Patent AU-2008203574-B2 (AU)
Title: An insulinotropic complex using an immunoglobulin fragment
Inventor: HOON KIM YOUNG
IPC: A61K38/28
Filed: 2008-01-04
Granted: 2011-12-01
Abstract: The present invention relates to an insulinotropic peptide conjugate having improved in-vivo duration of efficacy and stability, comprising an insulinotropic peptide, a non-peptide polymer and an immunoglobulin Fc region, which are covalently linked to each other, and a use of the same. The insulinotropic peptide conjugate of the present invention has the in-vivo activity which is maintained relatively high, and has remarkably increased blood half- life, and thus it can be desirably employed in the development of long acting formulations of various peptide drugs.
Patent AU-2008255529-B2 (AU)
Title: Ballistic projectile armour
Inventor: SCHULTE DARREN S
IPC: F41H5/04
Filed: 2008-05-23
Granted: 2012-11-08
Abstract: Ballistic projectile armour includes a hard shell, kinetic energy absorption material and an energy diffusing backing layer. The hard shell is made from a material capable of deforming a projectile and slowing a velocity of the projectile. The kinetic energy absorption material is capable of deforming to further slow and capture the projectile after it has pierced the hard shell. The energy diffusing backing layer is capable of diffusing energy transferred from the projectile into the kinetic energy absorption material. Elastic containment keeps the kinetic energy absorption material sandwiched between the hard shell and the energy diffusing backing, while accommodating expansion of the kinetic energy absorption material during energy absorption.
Patent AU-2008269686-B2 (AU)
Title: Compositions for anti-fibrinolytic treatment
Inventor: PARAMO FERNANDEZ JOSE ANTONIO
IPC: A61K38/36
Filed: 2008-06-26
Granted: 2013-01-10
Abstract: The present invention concerns the use of a neutralizing antibody for matrix metaloproteinase-10 (MMP-10) in the preparation of a medicine useful for anti-fibrinolitic treatment, and for haemorrages and haemorragic complications of various etiologies.
Patent AU-2008278956-B2 (AU)
Title: Cement compositions with a high photocatalytic power and an improved rheology
Inventor: GUERRINI GIAN LUCA
IPC: C04B24/20
Filed: 2008-07-24
Granted: 2013-08-29
Abstract: The present invention relates to new photocatalytic cement compositions, especially useful as paints, renders and plasters, provided with a high photocatalytic power and an optimal rheology, evaluated both in the step of preparing and in the step of applying. The compositions according to the invention specifically consist of a combination of organic additives, which, mixed with water and other components, provides cement compositions significantly more effective than the known compositions, both as far as rheology and photocatalytic power are concerned. The cement composition thus obtained associate features which have hardly been compatible up to now: on one side, a good workability (therefore a low viscosity) upon preparation from dry mixtures; on the other side, a good consistency in a wet state just after application. This avoids the occurrence of undesirable dripping before consolidation of the product. Finally, the photocatalytic power results surprisingly higher with respect to that of the known reference compositions when the same photocatalyst is used.
Patent AU-2008326037-B2 (AU)
Title: Oral stannous compositions
Inventor: STRAND ROSS
IPC: A61Q11/00
Filed: 2008-11-04
Granted: 2014-05-01
Abstract: The present invention relates to an aqueous oral composition comprising: a) from 0.2% to 3% divalent metal ions comprising: i. from 0.1% to 1.5% of zinc ions; ii. from 0.1% to 2% of tin (II) ions; and b) a source of fluoride ions; c) a silica dental abrasive; d) one or more chelants having a MW of less than 1000 and capable of forming water-soluble complexes with the zinc ions, wherein the chelants comprise less than 0.2% linear polyphosphates having a chain length of four or more; e) an orally acceptable carrier comprising at least 20% total water; wherein the pH of the composition is from 5 to 6.5, the molar ratio of the chelants to the divalent metal ions is at least 0.70: 1 and at least 80% by weight of the total zinc ions are solubilised within the composition. The composition of the invention has been found to give improved antimicrobial activity from the zinc / stannous combination without significant taste, staining or stability problems, compared to compositions having lower levels of chelants.